loading page

Perimyocarditis after COVID-19 mRNA Vaccine: The Role of Cardiac Magnetic Resonance Imaging
  • +4
  • Ashwin Kumar,
  • Evan Harmon,
  • Abdullah Yesilyaprak,
  • Ankit Agrawal,
  • Sayan Manna,
  • Paul Schoenhagen,
  • Allan Klein
Ashwin Kumar
Cleveland Clinic

Corresponding Author:kumar.402@osu.edu

Author Profile
Evan Harmon
Cleveland Clinic
Author Profile
Abdullah Yesilyaprak
Wayne State University
Author Profile
Ankit Agrawal
Cleveland Clinic
Author Profile
Sayan Manna
Mt. Carmel Health System
Author Profile
Paul Schoenhagen
Cleveland Clin
Author Profile
Allan Klein
Cleveland Clinic
Author Profile

Abstract

A 22-year-old male presented with chest pain 3 days after his second dose of the COVID-19 vaccine. Cardiac magnetic resonance imaging demonstrated myocardial and pericardial enhancement. Given imaging and clinical findings, he was diagnosed with perimyocarditis. He was treated with a multitude of medications including NSAIDs, colchicine, and steroids. Fortunately, he was able to achieve symptom improvement. Due to COVID-19 vaccination novelty, further research is needed to identify side effects.